Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Ambalal Sarabhai Enterprises Ltd - 500009 - Reply On Clarification For Significant Movement In Price

 With reference to the appended subject and email dated April 26, 2021, it is to inform you that the movement in price is due to the market demand and supply and there is no other price sensitive information/material event to be disclosed under Regulation 30 of SEBI LODR 2015. To the Company''s knowledge, currently there is no such information or event which is significant and price sensitive, which the company may need to disseminate to investors for their information. This is for your information and records please. Kindly acknowledge the receipt of same.
26-04-2021
Bigul

Ambalal Sarabhai Enterprises Ltd - 500009 - Clarification sought from Ambalal Sarabhai Enterprises Ltd

 The Exchange has sought clarification from Ambalal Sarabhai Enterprises Ltd on April 26, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
26-04-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Compliances - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended On 31St March,2021.

 We herewith submit Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the half year ended on 31st March,2021 which is given by M/s. Rajesh Parekh & Company, Company Secretaries, Ahmedabad.
21-04-2021
Bigul

Ambalal Sarabhai Enterprises Ltd - 500009 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, We enclose herewith a confirmation certificate received from MCS Share Transfer Agent Limited, the Registrar and Transfer Agent of the Company for the period ended on 31st March, 2021.
20-04-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Compliance - Compliance Certificate For The Half Year Ended 31St March,2021

 Certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("LODR Regulations") for the half year ended 31st March,2021.
20-04-2021
Bigul

Ambalal Sarabhai Enterprises Ltd - 500009 - Shareholding for the Period Ended March 31, 2021

 Ambalal Sarabhai Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
13-04-2021
Bigul

Ambalal Sarabhai Enterprises Ltd - 500009 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- DAMODAR HARGOVINDBHAI SEJPALDesignation :- Company Secretary and Compliance Officer
12-04-2021
Bigul

Ambalal Sarabhai Enterprises Ltd - 500009 - Closure of Trading Window

 We are hereby enclosing the intimation for Closure of Trading window. The trading window for the purpose of dealing in the equity shares of the Company shall remain closed from Thursday, April 1, 2021 up to 48 hours after declaration of financial results for the quarter and year ended March 31, 2021.
30-03-2021
Bigul

Ambalal Sarabhai Enterprises Ltd - 500009 - Announcement Under Regulation - 30 (LODR) Updates

 CoSara Diagnostics Private Limited, a Joint Venture of a subsidiary of Ambalal Sarabhai Enterprises Limited has received CDSCO License to manufacture SARAGENE(r) Chikungunya Virus (CHIKV) Test Kit. The detailed announcement has been attached herewith. You are requested to take the same on your record.
22-03-2021
Bigul

AMBALAL SARABHAI ENTERPRISES LTD. - 500009 - Announcement Under Regulation 30 Of SEBI (LODR) - Updates Of Completion Of Share Transfer

 In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company has entered into a Share Purchase Agreement (SPA) dated 27th November,2020 and amended on 2nd January,2021 & 5th March,2021 with Asence Pharma Private Limited , its step-down subsidiary (''Asence'') and Synbiotics Limited, its subsidiary(''Synbiotics'), for transfer of up to 100% equity shares of Synbiotics by the Company, in favour of Asence. Pursuant to the aforesaid SPA, the Company has transferred its 99.99% stake in Synbiotics to Asence on 5th March, 2021. Therefore, post the aforesaid transfer, Synbiotics has ceased to be the Company's wholly-owned subsidiary and has become a step down subsidiary of the Company w.e.f. 5th March, 2021. We are hereby enclosing the detailed updates on the same. You are requested to take the same on your record.
22-03-2021
Next Page
Close

Let's Open Free Demat Account